Angiogenesis is the formation of new blood vessels out of the preexisting vascular network and involves a sequence of events that are of key importance in a broad array of physiological and pathological processes. The growth of tumor and metastasis are dependent on the formation of new blood vessels. The present study therefore aims at evaluating the antiangiogenic effect of β β-carotene using in vivo and in vitro models. Male C57BL/6 mice as well as B16F-10 cells were used for the experimental study. The in vivo study includes the inhibitory effect of β β-carotene on the formation of tumor-directed capillaries. Rat aortic ring assay, human umbilical vein endothelial cell proliferation, migration, and tube formation are used for assessing the in vitro antiangiogenic effect of β β-carotene. The differential regulation of proinflammatory cytokines as well as the inhibitory effect of β β-carotene on the activation and nuclear translocation of transcription factors are also assessed. β β-Carotene treatment significantly reduces the number of tumor-directed capillaries accompanied by altered serum cytokine levels. β β-Carotene is able to inhibit proliferation, migration, and tube formation of endothelial cells. β β-Carotene treatment downregulates the expression of matrix metalloproteinase (MMP)-2, MMP-9, prolyl hydroxylase, and lysyl oxidase gene expression and upregulates the expression of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. The study reveals that β β-carotene treatment could alter proinflammatory cytokine production and could inhibit the activation and nuclear translocation of p65, p50, c-Rel subunits of nuclear factor-κ κB, and other transcription factors such as c-fos, activated transcription factor-2, and cyclic adenosine monophosphate response element-binding protein in B16F-10 melanoma cells. These observations show that β β-carotene exerts its antiangiogenic effect by altering the cytokine profile and could inhibit the activation and nuclear translocation of transcription factors.
Angiogenesis is a physiologic process that refers to the remodeling of the vascular tissue, which is characterized by the branching out of new blood vessels from the preexisting vessel. Angiogenesis is particularly active during embryogenesis, whereas during adult life, it is quiescent and limited to particular physiologic phenomena. Recently, the study of molecular mechanisms of angiogenesis has generated renewed interest because of the recognition of the role played by angiogenesis in several pathologies of significant medical impact, such as cancer and cardiovascular disease, and because of the pharmacologic interest rising from the possibility of modulating these phenomena. 1, 2 It is widely accepted that angiogenesis is the result of a net balance between the activities exerted by positive and negative regulators. These include cytokines such as interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-6, granulocyte monocyte-colony stimulating factor (GM-CSF), vascular endothelial growth factor (VEGF), and so forth. Chronic inflammation is also a contributor of neoangiogenesis. 3 Certain anti-inflammatory agents have been shown to inhibit angiogenesis, preferably by affecting COX-mediated metabolism, 4 thereby altering the levels of proinflammatory cytokines. Although several new antiangiogenic drugs of both synthetic and natural origin have been discovered, diseases such as cancer lack satisfactory solutions. It is thus considered important to screen antiangiogenic compounds from plants either in the form of crude extracts or as a component isolated from them.
Bioactive compounds are extranutritional constituents that typically occur in small quantities in foods. Carotenoids are a class of more than 600 natural pigments that are present in fruits and vegetables. 5 Among them, β-carotene is particularly attractive as it is known to exhibit various beneficial properties. Epidemiological studies have shown an inverse relationship between the intake of fruits and vegetables and the risk of several types of cancer 6 , and such effects of fruits and vegetables have been attributed to β-carotene. Most notably, β-carotene is shown to be an effective antioxidant by scavenging certain reactive oxygen species, especially peroxyl radical and singlet oxygen, and this antioxidant activity appears to be greatest at low oxygen tension. 7, 8 Our previous studies have shown the inhibitory effect of β-carotene on lung metastasis induced by B16F-10 melanoma cells in C57BL/6 mice. 9 Recently, we reported that β-carotene can downregulate inducible nitric oxide synthase (iNOS) gene expression and induce apoptosis by suppressing Bcl-2 expression and activating caspase-3 and p53 genes in B16F-10 melanoma cells. 10 However, the antiangiogenic potential of β-carotene and its effect on cytokine production in B16F-10 cells has not been revealed. In this study, we test the inhibitory effect of β-carotene on proliferation, migration, and tube formation of endothelial cells, the key steps of angiogenesis. Because matrix metalloproteinases (MMPs) play an important role in tissue remodeling during angiogenesis, the expression of MMP-2, MMP-9, and their inhibitors, TIMP-1 and TIMP-2, on B16F-10 cells was also evaluated. The expressions of prolyl hydroxylase and lysyl oxidase, the key enzymes required for the stabilization of collagen, were also evaluated. Moreover, the effect of β-carotene on the production of IL-1β, IL-6, GM-CSF, VEGF, and TNF-α as well as the activation or nuclear translocation of nuclear factor κ B (NF-κB) p65, NF-κB p50, NF-κB c-Rel, c-Fos, ATF-2, and cyclic adenosine monophosphate response element-binding protein (CREB) on B16F-10 cells were also evaluated.
Materials and Methods
Animals C57BL/6 mice were purchased from the National Institute of Nutrition (Hyderabad, India). The animals were maintained in ventilated cages, fed with normal mouse chow (Sai Feeds, Mumbai, India), and given water ad libitum. All the animal experiments were performed according to the rules of the Animal Ethics Committee, Government of India. (Figure 1 ) was purchased from Sigma Chemical Co (St Louis, Mo). All other chemicals used were of reagent or higher grade.
Reagents and Chemicals β-Carotene

Cells
B16F-10 melanoma cells were procured from the National Centre for Cell Sciences (Pune, India) and maintained in Dulbecco's modified Eagle's medium (DMEM; Himedia, Mumbai, India), supplemented with 10% fetal calf serum (FCS) and antibiotics.
Human umbilical vein endothelial cells (HUVECs) were prepared from human umbilical cord and were grown in HUVEC medium based on Jaffe's method. 11 HUVEC medium was made of medium 199 (HiMedia) supplemented with 20% fetal bovine serum (FBS), 100 U/mL penicillin, 100 µg/mL streptomycin, and 2 ng/mL growth factors such as VEGF and basic fibroblast growth factor. Incubation was carried out at 37°C in a 5% CO 2 incubator unless otherwise noted.
Enzyme-Linked Immunosorbent Assay Kit
Highly specific quantitative enzyme-linked immunosorbent assay (ELISA) kits for IL-1β, IL-6, GM-CSF, and TNF-α were purchased from Pierce Biotechnology (Rockford, III), and an ELISA kit for VEGF was purchased from R&D Systems (Minneapolis, Minn). The Cells-to-cDNA Kit II was purchased from Ambion (Foster City, Calif). A transcription factor-profiling kit was purchased from BD Biosciences (Palo Alto, Calif).
In Vivo Angiogenesis Assay
Angiogenesis was induced in 2 groups of animals (n = 6) by injecting B16F-10 melanoma (10 6 cells/ animal) intradermally on the shaven ventral skin of each mouse. 12 Group 1 animals were treated with 60 mg/kg of β-carotene (intraperitoneally [ip]) starting simultaneously with the tumor challenge. A total of 5 doses were given at a 24-hour interval. The other group of animals received only the vehicle, that is, 1% gum acacia (ip) and were kept as the control group.
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After 24 hours and 9 days after tumor challenge, blood was collected in a sterile manner from the caudal vein of each mouse. Serum was separated and used for the estimation of cytokines using ELISA kits according to the manufacturers' instructions.
After 9 days, all the animals were killed by decapitation, their ventral skin cut was removed and washed in phosphate-buffered saline (PBS), and the number of tumor-directed capillaries per cm 2 around the tumor was counted using a dissection microscope at 20× magnification. 13
In Vitro Angiogenesis Assay
The rat aortic ring assay was used as the in vitro angiogenesis study model. 14 Male Sprague Dawley rats (230 g) were killed by decapitation; their thoracic aorta was rapidly excised, rinsed in ice-cold PBS, and cut into 1-mm rings. Each segment was placed in a collagenprecoated, 96-well plate. The rings were then cultured along with 0.1 mL of conditioned media from B16F-10 melanoma cells for 6 days and then analyzed by phasecontrast microscopy for microvessel outgrowth.
In another experiment, the rings were cultured in 0.1 mL of conditioned medium along with escalating concentrations (1-10 µg/mL) of β-carotene, following the same procedure as above.
MTT Assay
HUVEC cells (5000 cells/well) were cultured in the presence of escalating concentrations of β-carotene (1-10 µg/mL), and the percentage cytotoxicity was assessed as explained previously. 15, 16 HUVEC Cell Proliferation Assay Cell proliferation was determined by the [ 3 H] thymidine incorporation assay. Briefly, HUVECs (5 × 10 4 cells per well) were seeded in 96-well plates. One day after seeding, cultures were exposed to increasing concentrations of β-carotene (1-10 µg/mL) for 48 hours, followed by incubation for 18 hours in the presence of [ 3 H] thymidine (1 µCi). After completing incubation, the medium was removed and DNA was precipitated with cold 10% perchloric acid solution and extracted with 1 mL of 0.5% NaOH. Recovered radioactivity was measured in a β-counter (Wallac 1209; Pharmacia, Uppsala, Sweden).
Wound Migration Assay
In vitro wound migration assay was carried out to investigate the formation of membrane protrution and cell migration. HUVECs (2 × 10 5 cells/well) were seeded into a collagen-coated, 96-well plate. When the confluence reached 90%, a single wound was created in the center of the cell monolayer by gently removing the attached cells with a sterile plastic tip. The debris was removed by washing the cells with serum-free medium. The cells were cultured in medium with increasing concentrations of β-carotene (1-10 µg/mL) along with VEGF (2 ng/mL) for 24 hours. Cells that migrated into the wounded area or cells with extended protrusion from the border of the wound were visualized and photographed (10×).
Tube Formation Assay
Tube formation of endothelial cells on Matrigel was performed as explained before 17 with modification. Ice-cold Matrigel (30 µL) was allowed to polymerize for 30 minutes at 37°C. HUVECs (1 × 10 3 cells/well) in 0.1 mL of culture medium with 20% FBS were seeded onto the surface of the Matrigel. In the presence of increasing concentrations of β-carotene (1-10 µg/mL), the cells were incubated for 48 hours, and then washed 3 times with PBS and fixed with 5% formaldehyde and stained with Diff Quick solution and photographed (20×).
Determination of the Effect of β β-Carotene on IL-1β β, IL-6, GM-CSF, and TNF-α α
Produced by B16F-10 Melanoma Cells B16F-10 melanoma cells (5 × 10 4 cells/well) were plated in 96-well, flat-bottom titer plate and incubated at 37°C in 5% CO 2 atmosphere in DMEM with 10% FCS. After 24 hours, the cells were washed and incubated for 24 hours in serum-free medium in the presence and absence of β-carotene (10 µg/mL). The total volume in the cells was 200 µL. The culture supernatant was collected and centrifuged, and concentrations of IL-1β, IL-6, GM-CSF, and TNF-α were determined by quantitative enzyme-linked immunosorbent assay (ELISA; Endogen, Rockford, III) according to the manufacturers' instructions.
Determination of the Effect of β β-Carotene on the Gene Expression Level of VEGF, MMP-2, MMP-9, TIMP-1, TIMP-2, Prolyl Hydroxylase, and Lysyl Oxidase
Total RNA was extracted from the B16F-10 tumorbearing lungs and cDNA was synthesized using Moloney murine leukemia virus reverse transcriptase. Polymerase chain reaction (PCR) was performed using specific primers of VEGF, MMP-2, MMP-9, TIMP-1, TIMP-2, prolyl hydroxylase, and lysyl oxidase ( Table 1) . PCR products were analyzed by agarose gel electrophoresis and photographed under ultraviolet light after staining with ethidium bromide.
Preparation of Nuclear Extracts
Nuclear extracts were prepared by slightly modified previously published methods. 18 B16F-10 cells were grown in a 25-cm 2 culture flask. When the cells were becoming subconfluent, they were treated with βcarotene (1-10 µg/mL) for 2 hours at 37°C in 5% CO 2 in serum-free medium. The cells were washed with phosphate-buffered saline (PBS) twice and incubated with TNF-α (10 pg/mL) for 30 minutes at 37°C in 5% CO 2 . Cells were washed with PBS, dislodged with a cell scraper, and collected by centrifugation at 450g. The cell pellet was resuspended in cell lysis buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 1 mM PMSF, 1 mM DTT, 0.5% Nonidet P40, 0.1 mM EGTA) and allowed to swell on ice for 15 minutes, followed by centrifugation at 3300g for 15 minutes. The cell pellet was resuspended in a volume of lysis buffer equal to twice the cell pellet volume. The cell suspension was slowly drawn down into a syringe and the contents ejected with a single rapid stroke. Disrupted cells were incubated for 15 minutes on ice, and the disrupted cell suspension was centrifuged at 11 000g for 20 minutes at 4°C. The nuclear pellet was resuspended in a volume of extraction buffer (20 mM HEPES, pH 7.9, 25% glycerol, 1.5 mM MgCl 2 , 420 mM NaCl, 0.1 mM PMSF, and 1 mM DTT) and incubated on ice for 30 minutes. The nuclear suspension was centrifuged at 21000g for 15 minutes at 4°C, and the supernatant was collected as nuclear extract and stored at -70°C. Protein concentrations were estimated using the standard Bradford method.
Transcription Factor Profiling
Transcription factor profiling was done with BD Mercury Transfactor kit obtained from BD Biosciences. This kit provided rapid, high-throughput detection of specific transcription factors, namely, subunits of NF-κB such as p65, p50, c-Rel; subunits of activated protein-1 (AP-1) such as c-fos and ATF-2; and CREB in the nuclear extract. Using an ELISAbased format, the transfactor kit detected the DNAbound transcription factors. 19 This method is faster, easier, and more sensitive than electrophoretic mobility shift assay and does not require radioactivity.
Each transcription factor-profiling kit was provided in a 96-well format with consensus DNA binding sequence. When nuclear extracts are added to the well, DNA will bind to their consensus sequences in the well. Bound transcription factors in the DNA were detected by specific primary antibody toward NF-κB p65, NF-κB p50, NF-κB c-Rel, c-Fos, ATF-2, and CREB. A horseradish peroxidase-conjugated secondary antibody was then used to detect the bound primary antibody. The enzymatic product was measured with a standard microtiter plate reader at 655 nm. Percentage inhibition was calculated by the formula 100 -([OD ofβ-carotene treated/OD of control] × 100).
Statistical Analysis
Results were expressed as mean ± standard deviation. Statistical evaluation was done by Student t test. P < .05 was considered to be statistically significant.
Results
Effect of β β-Carotene on in Vivo Angiogenesis
Tumor angiogenesis was induced by injecting 10 6 B16F-10 melanoma cells per animal. The number of tumor-directed capillaries was significantly reduced by the β-carotene treatment. The control animals had an average number of 32.0 ± 2.0 capillaries around the tumor (Figure 2a ), whereas the treated animals Table 1 . Primer Sequence of TIMP-1, TIMP-2, MMP-2, MMP-9, VEGF, Prolyl Hydroxylase, and Lysyl Oxidase
Mouse Gene
Primer Sequence Product Size had only 12.65 ± 2.6 capillaries (Figure 2b) , showing 60.93% inhibition in neovessel formation ( Table 2) .
Effect of β β-Carotene on Serum Cytokine and TIMP-1 Levels
The level of proinflammatory cytokines such as IL-1β, TNF-α, and IL-6 in the serum of angiogenesis induced animals showed a varying pattern during the period of study. In control animals, the level of IL-1β in the serum was doubled 24 hours after cell inoculation compared with normal animals. Administration of β-carotene did not affect the initial level of this cytokine at 24 hours, but it effectively reduced the level by day 9 after tumor inoculation ( Table 3) . TNFα and IL-6 levels were significantly increased in the serum of angiogenesis-induced control animals after the 9th day of tumor inoculation compared to normal animals. Administration of β-carotene significantly downregulated the elevated level of TNF-α and IL-6 by the 9th day of tumor induction (Table 3 ).
Serum GM-CSF level was highly elevated 24 hours after tumor challenge in the untreated control animals compared to normal levels and by day 9, the level was found to be reduced. β-carotene treatment reduced the initial elevation and by day 9, the serum GM-CSF levels were found to be significantly increased after the 9th day of tumor induction compared to normal animals. Administration of β-carotene could significantly lower the elevated level of VEGF after the 9th day of tumor induction ( Table 3 ).
The IL-2 levels in the β-carotene-treated animals on day 9 were found to be significantly enhanced compared to the control animals. Similarly, the tissue inhibitor of metalloprotease level also showed a significant increase after β-carotene treatment compared to control animals, thereby negatively contributing to the formation of neovessels ( Table 3) .
Effect of β β-Carotene on in Vitro Angiogenesis
Incubation of aortic rings with β-carotene at various concentrations showed a significant and dosedependent inhibition of microvessel outgrowth from the rat aorta ring induced by the conditioned medium from B16F-10 cells (Figure 3) , with the microvessel outgrowth totally stopped at 10 µg/mL.
Cell Viability by MTT Assay
β-Carotene was found to be 100% cytotoxic to HUVEC as well as B16F-10 cells at a concentration of Values are mean ± SD (n = 6). ***P < .001. GM-CSF = granulocyte monocyte-colony stimulating factor; IL = interleukin; TIMP = tissue inhibitor of metalloproteinase; TNF = tumor necrosis factor; VEGF = vascular endothelial growth factor. Values are mean ± SD (n = 6). *P < .05. ***P < .001.
Cytokines, (pg/mL) 100 µg/mL but was nontoxic at a concentration of 10 µg/mL ( Table 4 ).
Effect of β β-Carotene on Endothelial Cell Proliferation
Rate of proliferation was determined by 3 H-thymidine incorporation by the DNA of HUVECs. Thymidine incorporation is proportional to the potential of the cells to synthesize DNA. Proliferation was expressed as radioactive count per minute (cpm). HUVECs showed a very high rate of proliferation (4856 ± 102.8 cpm) when stimulated with VEGF. Administration of β-carotene at a concentration of 10 µg/mL significantly inhibited (58.03%) VEGFinduced proliferation of HUVECs. Considerable inhibition of proliferation was also observed when βcarotene was treated at concentrations of 1 µg/mL (16.59%) and 5 µg/mL (32.90%; Table 5 ).
Effect of β β-Carotene on Endothelial Cell Migration
The effect of β-carotene on the motility of HUVECs is shown in Figure 4 . HUVECs migrated into the clear area when stimulated with VEGF ( Figure 4b ). βcarotene significantly inhibited the VEGF-induced migration of endothelial cells in a dose-dependent manner (Figure 4c, d, and e ). Almost complete inhibition of endothelial cell migration was observed at 10 µg/mL of β-carotene ( Figure 4e ) and looked like that of zero-hour incubation (Figure 4a ). This concentration is nontoxic, as is evident from the MTT assay, and hence the inhibitory effect could not be attributed to cytotoxic activity.
Effect of β β-Carotene on Endothelial Cell Tube Formation
Treatment of HUVECs with β-carotene significantly inhibited tube formation ( Figure 5 ). Incubation of HUVECs on Matrigel with VEGF resulted in the formation of elongated tubelike structures (Figure 5a ). β-Carotene effectively reduced the width and length of endothelial tubes in a dose-dependent manner, and maximum inhibition was observed at 10 µg/mL (Figure 5d ).
Effect of β β-Carotene on IL-β β, IL-6, GM-CSF, and TNF-α α Produced by B16F-10 Melanoma Cells
The proinflammatory cytokine level in the culture supernatant was determined by quantitative ELISA. B16F-10 cells produced very high levels of proinflammatory cytokines. β-Carotene at a concentration of 10 µg/mL significantly (P < .001) reduced the proinflammatory cytokine production (Table 6 ) by the B16F-10 cells.
Effect of β β-Carotene on the Gene Expression
Level of VEGF, MMP-2, MMP-9, TIMP-1, TIMP-2, Prolyl Hydroxylase, and Lysyl Oxidase β-Carotene treatment downregulated MMP-2, MMP-9, VEGF, prolyl hydroxylase, and lysyl oxidase gene expression. Highly elevated expression of TIMP-1 and TIMP-2 genes was observed after β-carotene treatment when compared with untreated control animals ( Figure 6 ).
Effect of β β-Carotene on the Translocation of Transcription Factors
DNA-bound transcription factor was detected by the primary antibody. A horseradish peroxidase-conjugated secondary antibody was then used to detect the primary antibody. The enzymatic product was measured spectrophotometrically. β-Carotene inhibited the translocation of NF-κB subunits such as p65, p50, and c-Rel. We also found that β-carotene inhibited the nuclear translocation of c-fos, ATF-2, and CREB (Table 7) .
Discussion
Epidemiologic studies, clinical intervention trials, and laboratory experiments have suggested the protective effect of carotenoids in the incidence of various cancers, [20] [21] [22] but contradictory results have also been published. 23 The roles of β-carotene in the pathogenesis of cancer have been contradictory and certainly intriguing. Angiogenesis is essential for a tumor to become Herein, we focused on studying the potential effect of β-carotene on the process of angiogenesis itself using vascular endothelial cells as a model. We demonstrated that β-carotene could inhibit tube formation of HUVECs using an in vitro Matrigel assay. Matrigel is a matrix of mouse basement membrane neoplasm, which represents a complex mixture of basement membrane proteins including type IV collagen, entactin/nitrogen, proteoheparan sulfate, and other growth factors. Matrigel can induce endothelial cells to differentiate (as shown by morphological changes) and is a widely accepted model to study biochemical changes associated with angiogenesis. 24 The inhibition of tube formation, as observed in our study after β-carotene treatment, might be due to the reduced proliferation of endothelial cells. The concentrations of β-carotene used in the present studies did not interfere with the cell viability of endothelial cells. The decreased number of tumor-directed capillaries in β-carotenetreated animals also indicates its potential to selectively inhibit the tumor-specific capillary sprouting. Our findings appear to contradict the recent findings of Dembinska et al, 25 who reported that β-carotene in the physiological concentration range stimulates angiogenesis by the activation of cellular migration as well as matrix reorganization and decrease of cell adhesion.
In our experiments, we used an elevated and possibly nonphysiological concentration of β-carotene in the analyses. These findings suggest that β-carotene at nonphysiological concentrations could inhibit the key steps of angiogenesis such as endothelial cell migration and tube formation. β-Carotene at lower concentrations tested (5 µg/mL and less) could produce much less inhibition in endothelial cell migration and tube formation compared with the higher concentration used (10 µg/mL), which strongly supports our findings. Angiogenesis is a significant prognostic factor in melanoma, and several endogenous factors control the process of neovascularization. 26 The inflammatory cytokines evaluated in this study are also important in the process of angiogenesis. Because many of the proinflammatory cytokines and proangiogenic factors are NF-κB dependent, 27,28 their deregulated expression directly correlates with the metastatic potential of several carcinomas. 29, 30 In this study, we attempted to determine the level of some proinflammatory cytokines in angiogenesis-induced animals and to correlate with the extent of angiogenesis.
More recently, some cytokines have been implicated as putative mediators of angiogenesis. 31 Cytokines act as soluble mediators of immune responses participating in the communication and regulation of inflammatory responses. 32 Cytokines and angiogenic factors produced by macrophages, mast cells, and fibroblasts stimulate vessel growth. 33 In head and neck squamous cell carcinoma patients, proinflammatory cytokines such as IL-6 and GM-CSF are highly expressed. 34 IL-6 is a growth factor for hematological malignancies and is found to stimulate VEGF. 35 Here, administration of β-carotene significantly reduced the IL-6 level and thus inhibited the tumor-directed capillaries in the angiogenesis-induced animals. IL-1β, a multifunctional, inflammatory cytokine, affects nearly all cell types, often in concert with other cytokines or small mediators. 36 The necessity of IL-1β for in vivo angiogenesis driven by B16 melanoma has clearly been documented. IL-1β knockout mice showed a lesser degree of microvessel formation compared to wild type when induced with B16 melanoma, 37 indicating the importance of host-derived IL-1β in angiogenesis.
The result obtained in this study indicates that β-carotene could also inhibit the IL-1β production, which in turn inhibits neovascularization.
The major sources of TNF-α are macrophages and to a lesser extent T lymphocytes, proliferating B cells, and NK cells. 38 TNF-α exerts its regulatory effect on both iNOS and VEGF and has been found to upregulate MMP-9 expression and thereby angiogenesis. 39, 40 TNF-α is among the most potent inducers of transcription factor NF-κB, which has been recognized as a major regulator of pathogen and inflammatory cytokine-inducible gene regulation. 41 Treatment with β-carotene could inhibit the TNF-α level in angiogenesisinduced animals, thus preventing tumor-directed new blood vessel formation by downregulating other angiogenic molecules. GM-CSF, a pleiotropic cytokine, takes part in angiogenesis events including differentiation of angioblast into endothelial cells and their migration and proliferation. 42 As observed in our study, treatment with β-carotene downregulated GM-CSF production and thereby blocked tumor-specific angiogenesis. The elevation of these cytokines (IL-6, IL-1β, TNF-α, and GM-CSF) is strictly proangiogenic, and treatment with β-carotene could decrease and inhibit angiogenesis. Moreover, β-carotene was able to increase the production of IL-2 and TIMP-1 and could successfully shift the equilibrium toward an angiostatic consition. The in vitro experiments have again established the antiangiogenic activity of the drug. VEGF is a potent growth factor for blood vessel endothelial cells, which show pleiotropic responses that facilitate migration and proliferation, stimulated by TNF-α, IL-1β, and IL-6. 35, 43 We demonstrated that β-carotene could inhibit the VEGF-induced migration and tube formation of HUVECs in vitro. This inhibition is unlikely to be caused by the effect of β-carotene on the proliferation of endothelial cells since our data showed that β-carotene did not interfere with the cell viability of endothelial cells. The antiangiogenic activity of β-carotene was supported by its remarkable suppression in sprouting of endothelial cells in rat aorta.
Tumor and stromal cells produce soluble and cell surface-anchored MMPs, which mediate extracellular matrix degradation, release of sequestered latent growth and angiogenic factors, and activation of latent growth factors. The proteolytic activity of MMPs is controlled by the so-called TIMPs. Studies in experimental mouse models have revealed that enhanced TIMP expression can decrease metastasis and inhibit angiogenesis. [44] [45] [46] Angiogenesis requires the deposition of mature type IV collagen by endothelial cells into the basement membrane of new blood vessels. 47 Stabilization of type IV collagen triple helix depends on the hydroxylation of proline, which is catalyzed by the iron-containing enzyme prolyl hydroxylase. 48 Lysyl oxidase (proteinlysine-6-oxidase) is a copper-dependent metalloenzyme that catalyzes a key step in the cross-linking of collagen and elastin in the extracellular matrix. 49, 50 In cancer biology, abnormalities of lysyl oxidase expression have been implicated in tumor suppression as well as the pathobiology of tumor invasion. 51 A putative tumor-suppressive role for lysyl oxidase has been inferred from a variety of in vitro studies demonstrating decreased lysyl oxidase expression in cancer lines and transformed cell lines. Lysyl oxidase expression is upregulated in squamous cell carcinoma arising in oral submucous fibrosis and localizes to invading epithelial islands at the front of tumor progression. 52 In the present study, β-carotene treatment was found to downregulate the expression of prolyl hydoxylase and lysyl oxidase in B16F-10 melanoma-bearing lungs. Further studies will shed considerable light on the effect of β-carotene on the complex and varied functions of lysyl oxidase in cancer biology.
NF-κB proteins have been implicated as playing a role in cellular transformation by either providing a continued positive growth stimulus such as that mediated by cytokines or through inhibition of apoptotic pathways. 53 Activated or nuclear translocated NF-κB proteins are overexpressed in malignancies such as colorectal cancer, breast cancer, T-cell leukemia, and pancreatic adenocarcinoma. [54] [55] [56] The prototypical NF-κB is a heterodimer composed of p50 and p65 subunits, which are the most frequent components of active NF-κB. Subunit p65-containing complexes bind with high affinity to the consensus DNA sequences 5′-GGGPuNNPyPyCC-3′ (p65/p50) or 5′-GGGPuNPyPyCC-3′ (p65/c-Rel) leading to the activation of transcription. 57 Many other heterodimers such as c-Rel/p52, RelB/p50, and c-Rel/p50 and homodimers such as p50/p50 and p52/p52 have also been found in different cell types, which may vary depending on the cell types and stimuli. 58 Transcription factor AP-1 consists of homodimers and heterodimers of Jun (v-Jun, c-Jun, Jun-B, and Jun-D), Fos (v-Fos, c-Fos, FosB, Fra 1, and Fra 2), or activating transcription factor (ATF-2, ATF-3, and B-ATF) proteins. 59 Similar to NF-κB, AP-1 and its components regulating gene expression have been shown to play an important role in cell proliferation, cell cycle regulation, and tumor promotion. 59, 60 Fos proteins form heteromeric dimers with members of the Jun family to generate AP-1 complexes with transcriptional activity. 56 Such transcription factors are involved in the regulation of AP-1-dependent genes and are critical for cellular processes such as cell proliferation or invasion. 61, 62 Since induction of Fos is a prerequisite for cytokine-induced metalloproteinase gene expression, higher expression of these genes may exert deleterious consequences to connective tissue integrity in inflammatory disorders, and it is critical to convey the invasive phenotype of tumor cells. 63, 64 Activation of the AP-1 protein is required for the preneoplastic to neoplastic progression of different cancers, such as prostate cancer and epithelial cancer, 65, 66 and nuclear translocation of c-Fos and ATF-2 has been reported in different cancer cells. 67, 68 CREB is a cyclic AMP response element-binding protein, which is activated through protein kinase A and mediates phosphorylation in the signaling cascade; CREB binds to the cyclic AMP response element sequence and promotes the specific gene transcription. 69, 70 In the present study, we found that β-carotene could inhibit the activation or nuclear translocation of transcription factors such as NF-κB p65, NF-κB p50, NF-κB c-Rel, c-Fos, ATF-2, and CREB.
Conclusion
All the above results indicate that β-carotene possesses very good antiangiogenic qualities and could inhibit the activation of transcription factors. This inhibition may be attributable to the interference with signaling cascades, which may inhibit the expression of several proinflammatory cytokines, MMPs, and TIMPs. Further studies have to be conducted to elucidate the mechanism of action of β-carotene in the inhibition of angiogenesis and to investigate how it can be used in cancer therapy.
